Last Updated : September 18, 2019
Details
FilesProject Line:
Reference List
Project Sub Line:
Reference List
Project Number:
RA1068-000
Question
- What is the clinical effectiveness of cabergoline versus bromocriptine as a first-line medication therapy for patients with hyperprolactinemia with or without prolactinoma?
- What is the cost-effectiveness of cabergoline versus bromocriptine as a first-line medication therapy for patients with hyperprolactinemia with or without prolactinoma?
- What is the clinical effectiveness of quinagolide versus bromocriptine as a first-line medication therapy for patients with hyperprolactinemia with or without prolactinoma?
- What is the cost-effectiveness of quinagolide versus bromocriptine as a first-line medication therapy for patients with hyperprolactinemia with or without prolactinoma?
- What are the evidence-based guidelines regarding medication therapy for patients with hyperprolactinemia with or without prolactinoma?
Files
Last Updated : September 18, 2019